Latest Loan Facilities News

Page 73 of 81
Kingston Resources Limited reported a $1.07 million net cash outflow from operating activities in the December 2024 quarter, maintaining a solid cash balance of nearly $9.9 million supported by a $15 million secured loan facility.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Elementos Limited reports significant progress in its Oropesa and Cleveland tin projects, positioning itself as a key supplier in Europe amid tightening global tin markets.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Vertex Minerals has completed construction and begun commissioning of its Gravity Gold plant at the Reward Gold Mine, supported by significant capital raises and strategic hires.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tasman Resources has identified six promising drill targets at its Parkinson Dam gold project in South Australia, supported by advanced geophysical analysis and a new high-resolution gravity survey. The company also highlights ongoing investment in Eden Innovations and strategic funding moves.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tartana Minerals reports robust copper sulphate sales and completes a significant acquisition, positioning itself as a leading explorer and developer in Far North Queensland.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Latin Resources has secured shareholder and court approvals for its acquisition by Pilbara Minerals, marking a pivotal transition for the Salinas Lithium Project in Brazil. The deal positions Salinas as a key global lithium asset under new stewardship.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Uscom Limited reports a 56% increase in cash on hand to $2.17 million for Q2 2024, driven by strategic moves in China and new product regulatory approvals.
Victor Sage
Victor Sage
31 Jan 2025
Titan Minerals has made significant strides in its Ecuadorian copper and gold projects, securing a $20 million capital raise and progressing key drilling milestones under a major joint venture agreement.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Core Energy Minerals Ltd has fortified its uranium exploration ambitions with a $3.7 million capital raise and strategic acquisitions in South Australia, setting the stage for a busy 2025 exploration calendar.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.
Ada Torres
Ada Torres
31 Jan 2025
Astron Corporation Limited reported a $1.05 million net cash outflow from operations in Q4 2024 but strengthened its liquidity position with a $14.5 million inflow from financing activities, ending the quarter with $13.48 million in cash.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Eden Innovations Ltd reports a striking 158% increase in US OptiBlend® sales for Q2 FY25, alongside expanding international traction for its EdenCrete® products and strategic property sales aimed at debt reduction.
Maxwell Dee
Maxwell Dee
31 Jan 2025